L01FG VEGF/VEGFR (vascular endothelial growth factor) inhibitors VEGF/VEGFR (vascular endothelial growth factor) inhibitors VEGF/VEGFR (vascular endothelial growth factor) inhibitors VEGF/VEGFR (vascular endothelial growth factor) inhibitors L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
2 active ingredients 2 principios activos 2 个活性成分 2 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Bevacizumab
L01FG01active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Ramucirumab
L01FG02active US GB CA SG CN · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA SG CN ES TW EU FR · discontinued MX · unknown HK
By dosage form, across markets
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).